Sir: As an immune escape mechanism, tumour cells may down‐regulate expression of human leucocyte antigens (HLA). Loss of HLA classes I and II has been described in various subtypes of diffuse large B cell lymphoma (DLBCL), including the not otherwise specified (NOS) subgroup. We analysed HLA classes I and II expression in DLBCL‐NOS to investigate whether there is an association between HLA expression, cell of origin (COO) and the recently reported FoxP1 expression in non‐GCB DLBCL.Seventy‐seven cases of DLBCL‐NOS with an almost exclusively nodal presentation were classified for COO by immunohistochemistry (IHC) according to the Hans algorithm as germinal centre B (GCB) cell‐type (n = 42) or non‐GCB‐type (n = 35) (Table ). Clinical data available from 67 cases indicated a histologically confirmed pre‐existent or concurrent indolent lymphoma in 16 patients, i.e. 13 follicular lymphoma, two marginal zone lymphoma and one chronic lymphocytic leukaemia. Expression of HLA and FoxP1 was assessed by IHC; methods are described in the Supporting Information.Features of DLBCL‐NOS casesCharacteristicNon‐GCB (35)GCB (42)P‐valueMale (%)23 (66)24 (57)Median age (years; range)66 (9–85)56 (14–77)Ann Arbor stageI/II (%)6 (17)18 (43)III/IV (%)26 (74)18 (43)Unknown (%)3 (9)6 (14)IPI0–1 (%)5 (14)13 (31)2–3 (%)19 (55)18 (43)4–5 (%)7 (20)1 (2)Unknown (%)4 (11)10 (24)Transformation (%)2 (6)14 (33)<0.01HLA
Histopathology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera